How does CBD’s interaction with anandamide receptors affect appetite regulation?

🧠 While cannabidiol (CBD) is increasingly marketed for appetite modulation, the current evidence base regarding its interaction with endocannabinoid signaling remains incomplete and somewhat contradictory. CBD’s pharmacology is complex and involves multiple receptor systems beyond classical cannabinoid receptors, making it difficult to isolate specific effects on anandamide-mediated appetite regulation in clinical populations. Most mechanistic studies are conducted in animal models or in vitro, and human data on CBD’s actual impact on hunger, satiety, and eating behavior remain limited, particularly across different dosages, formulations, and patient subgroups such as those with eating disorders or cachexia. Clinicians should be cautious about attributing appetite changes in patients using CBD products to well-characterized endocannabinoid mechanisms, as placebo effects, dietary changes, and concurrent medications may play significant confounding roles. When patients report appetite alterations following CBD use